SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-22-104790
Filing Date
2022-09-30
Accepted
2022-09-30 21:45:46
Documents
2
Period of Report
2022-09-28

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2227191-4_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm2227191-4_3seq1.xml 3 1642
2 EXHIBIT 24 tm2227191d4_ex24.htm EX-24 5687
  Complete submission text file 0001104659-22-104790.txt   8838
Mailing Address 505 EAGLEVIEW BOULEVARD SUITE 212 EXTON PA 19341
Business Address 505 EAGLEVIEW BOULEVARD SUITE 212 EXTON PA 19341 4843481600
IDERA PHARMACEUTICALS, INC. (Issuer) CIK: 0000861838 (see all company filings)

IRS No.: 043072298 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O ACERAGEN, INC. 15 TW ALEXANDER DRIVE DURHAM NC 27709
Business Address
Taylor John Clayton (Reporting) CIK: 0001947029 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-31918 | Film No.: 221285720